Skip to main content
. 2024 Feb 8;35(1):123–133. doi: 10.31138/mjr.140223.sof

Table 3.

COVID-19 infection after vaccination.

First dose No. (%) Second dose No. (%)
COVID-19 diagnosis after each type of vaccination Pfizer 6(75.0) 14(63.6)
Sinopharm 2(25.0) 4(18.2)
AstraZeneca 0(0.0) 4(18.2)
Median(range) Median(range)
Days after vaccination infection with COVID had occurred Pfizer 9(3–15) 50(1–190)
Sinopharm 10.50(7–118) 45(14–60)
AstraZeneca 0(0) 37(14–80)